Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

IVERMECTIN

IVERMECTIN

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview IVERMECTIN is listed in Drugs@FDA under application 212485 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IVERMECTIN Form and strength LOTION;TOPICAL - 0.5% Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2022-03-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview IVERMECTIN is listed in Drugs@FDA under application 212485 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IVERMECTIN Form and strength LOTION;TOPICAL - 0.5% Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2022-03-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.